Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Wyss Institute’s eRapid technology licensed to The iQ Group Global

Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University announced that its eRapid technology has been licensed to The iQ Group Global for COVID-19 diagnostic applications.

30 Nov 2020

SARS-CoV-2 immunity in the U.S. remains low

Seroprevalence studies indicate that less than 10% of people in the U. S. have detectable antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from July to September 2020.

30 Nov 2020

A mutant SARS-CoV-2 subspecies from minks may evade antibody detection

In a recent research letter published on the bioRxiv preprint server, scientists from Japan discovered that the mutation of spike glycoprotein in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) derived from farmed minks can also be found in the group of individuals with coronavirus disease (COVID-19) and subsequently evade detection by our immune system.

30 Nov 2020

Rutgers leading a clinical trial assessing combination treatment for coronavirus

Rutgers is leading a clinical trial assessing the combination of nitazoxanide, ribavirin and hydroxychloroquine to treat people 21 or older who are infected with SARS-CoV-2 and are asymptomatic or mildly symptomatic.

30 Nov 2020

Virus induced lymphocytes show promise for COVID-19 and future pandemics

Researchers in the United States have conducted a study demonstrating the potential of a novel therapeutic approach to treating coronavirus disease 2019 (COVID-19). The therapy augments the body’s T cell response to the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by providing a boost of rapidly expanded virus-specific T cells.

30 Nov 2020

Highly functional immune response in asymptomatic SARS-CoV-2 infection

Researchers in Singapore have conducted a study showing that asymptomatic individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – mount an efficient, balanced and coordinated cellular immune response that protects the host without appearing to trigger any pathological processes.

30 Nov 2020

Mollusc-derived compounds potential medicines for COVID-19 and other respiratory diseases

A research team has reviewed the existing literature on compounds derived from molluscs used for treating respiratory diseases.

30 Nov 2020

Mexican case study finds similar mortality rates in diabetic patients with and without COVID-19

In a large case study based in Mexico, researchers recently examined the mortality risk associated with diabetes in symptomatic COVID-19 patients.

30 Nov 2020

What are the risks associated with human challenge trials for SARS-CoV-2 vaccine candidates?

Researchers from the University of Haifa, Israel, and WAW Statistical Consulting Ltd, UK, designed a model that helps determine the risks faced by participants in a hypothetical COVID-19 dosing study.

30 Nov 2020

Transmission 'hot zones' drive COVID-19 infection patterns, says study

A recent study describes two different mathematical models of high infection zones, which lead to different effects on viral transmission. This underlines the need to understand how the virus spreads within a community as well as within subgroups with different patterns of interaction.

30 Nov 2020

Severe COVID-19 can produce high long-term neutralizing antibodies, study finds

A new study published by a team of scientists in Spain indicates that neutralizing immunity can last for up to 8 months, despite a steep drop in antibody titer over this time.

30 Nov 2020

Are SARS-CoV-2 protease inhibitors effective antivirals in treating COVID-19?

Many antiviral development studies have focused on the possibility of inhibiting the main viral protease (Mpro), and papain-like protease (PLpro), given their central role in viral replication. A new study draws attention to the high odds that these may not have anti-infective activity because of the redundant pathways present in human host cells.

30 Nov 2020

UK’s post-lockdown COVID-19 restrictions allows families to celebrate Christmas 2020 together

The UK's three-tier system of COVID-19 restrictions could be tweaked to allow a more effective control of viral spread, while still ensuring that families can choose their own course of action over the Christmas holidays, says a new preprint published on the medRxiv* server in late November 2020.

30 Nov 2020

Excessive use of antibiotics during COVID-19 pandemic could intensify drug resistance

A new study published in the journal Science of The Total Environment in November 2020 discusses this potentially serious issue along with its wider consequences.

30 Nov 2020

‘An Arm and a Leg’: How to avoid a big bill for your COVID test

Tests for the coronavirus are supposed to be free. And, usually, they are. But sometimes … things happen. Here's how to keep those things from happening to you.

30 Nov 2020

Could the keto diet help prevent or mitigate severe COVID-19?

A new study published in the journal of Translational Medicine reports that the ketogenic diet (KD) may be useful in this area, with its track history of effectual reduction of fat mass, anti-inflammatory and immunomodulatory effects, and consequent improvement of cardiovascular health.

30 Nov 2020

Wuhan mass screening program finds 300 asymptomatic cases

A mass screening programme of more than 10 million Wuhan residents identified 300 asymptomatic cases, but none were infectious - according to a study involving the University of East Anglia.

30 Nov 2020

Thousands of doctors’ offices buckle under financial stress of COVID

Cormay Caine misses a full day of work and drives more than 130 miles round trip to take five of her children to their pediatrician. The Sartell, Minnesota, clinic where their doctor used to work closed in August.

30 Nov 2020

How pharma money colors Operation Warp Speed’s quest to defeat COVID

April 16 was a big day for Moderna, a Massachusetts biotech company on the verge of becoming a front-runner in the U.S. government's race for a coronavirus vaccine. It had received roughly half a billion dollars in federal funding to develop a COVID shot that might be used on millions of Americans.

30 Nov 2020

Steam inhalation therapy found to inactivate SARS-CoV-2 virions

Researchers have published a study on the efficacy of steam inhalations as another possible treatment to help mitigate SARS-CoV-2 infection.

30 Nov 2020

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Wyss Institute’s eRapid technology licensed to The iQ Group Global

SARS-CoV-2 immunity in the U.S. remains low

A mutant SARS-CoV-2 subspecies from minks may evade antibody detection

Rutgers leading a clinical trial assessing combination treatment for coronavirus

Virus induced lymphocytes show promise for COVID-19 and future pandemics

Highly functional immune response in asymptomatic SARS-CoV-2 infection

Mollusc-derived compounds potential medicines for COVID-19 and other respiratory diseases

Mexican case study finds similar mortality rates in diabetic patients with and without COVID-19

What are the risks associated with human challenge trials for SARS-CoV-2 vaccine candidates?

Transmission 'hot zones' drive COVID-19 infection patterns, says study

Severe COVID-19 can produce high long-term neutralizing antibodies, study finds

Are SARS-CoV-2 protease inhibitors effective antivirals in treating COVID-19?

UK’s post-lockdown COVID-19 restrictions allows families to celebrate Christmas 2020 together

Excessive use of antibiotics during COVID-19 pandemic could intensify drug resistance

‘An Arm and a Leg’: How to avoid a big bill for your COVID test

Could the keto diet help prevent or mitigate severe COVID-19?

Wuhan mass screening program finds 300 asymptomatic cases

Thousands of doctors’ offices buckle under financial stress of COVID

How pharma money colors Operation Warp Speed’s quest to defeat COVID

Steam inhalation therapy found to inactivate SARS-CoV-2 virions

Industry Focus eBook - Infectious Diseases (1st Edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Industry Focus eBook - Infectious Diseases (1st Edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in